This inventor holds 1 USPTO granted patent. Top assignee: Arzneimittelwerk Dresden Gmbh. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Oleg M Glozman: Innovator in Cerebroprotective Compounds
Introduction
Oleg M Glozman is a notable inventor based in Moskau, SU. He has made significant contributions to the field of medicine, particularly in the development of compounds with cerebroprotective effects. His work is aimed at addressing cerebral functional disorders, which are critical in human health.
Latest Patents
Glozman holds a patent for N-acyl-4-phenyl-pyrrolidin-2-ones and the method for preparing these compounds. This invention focuses on N-acetyl-4-phenyl-pyrrolidin-2-ones, which exhibit pronounced cerebroprotective effects. These compounds can be utilized for the prophylaxis and treatment of various cerebral functional disorders. The synthesis of these compounds involves reacting 4-phenyl-pyrrolidin-2-ones with a reactive derivative of a carboxylic acid or cyclizing N-acylaminobutyric acid derivatives.
Career Highlights
Oleg M Glozman is associated with Arzneimittelwerk Dresden GmbH, where he continues to innovate in the pharmaceutical field. His work has the potential to significantly impact the treatment of neurological conditions, showcasing his dedication to advancing medical science.
Collaborations
Glozman has collaborated with notable colleagues such as Lothar Zenker and Helmut Wunderlich. These partnerships have likely contributed to the success of his research and the development of his patented compounds.
Conclusion
Oleg M Glozman is a distinguished inventor whose work in cerebroprotective compounds is paving the way for advancements in treating cerebral disorders. His contributions to the field of medicine are invaluable and highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile